Literature DB >> 10872462

In vitro selection of functional nucleic acids.

D S Wilson1, J W Szostak.   

Abstract

In vitro selection allows rare functional RNA or DNA molecules to be isolated from pools of over 10(15) different sequences. This approach has been used to identify RNA and DNA ligands for numerous small molecules, and recent three-dimensional structure solutions have revealed the basis for ligand recognition in several cases. By selecting high-affinity and -specificity nucleic acid ligands for proteins, promising new therapeutic and diagnostic reagents have been identified. Selection experiments have also been carried out to identify ribozymes that catalyze a variety of chemical transformations, including RNA cleavage, ligation, and synthesis, as well as alkylation and acyl-transfer reactions and N-glycosidic and peptide bond formation. The existence of such RNA enzymes supports the notion that ribozymes could have directed a primitive metabolism before the evolution of protein synthesis. New in vitro protein selection techniques should allow for a direct comparison of the frequency of ligand binding and catalytic structures in pools of random sequence polynucleotides versus polypeptides.

Entities:  

Keywords:  NASA Discipline Exobiology; Non-NASA Center

Mesh:

Substances:

Year:  1999        PMID: 10872462     DOI: 10.1146/annurev.biochem.68.1.611

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  281 in total

1.  An in vitro evolved precursor tRNA with aminoacylation activity.

Authors:  H Saito; D Kourouklis; H Suga
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Cooperative binding of effectors by an allosteric ribozyme.

Authors:  A M Jose; G A Soukup; R R Breaker
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

3.  Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801.

Authors:  G P Hess; H Ulrich; H G Breitinger; L Niu; A M Gameiro; C Grewer; S Srivastava; J E Ippolito; S M Lee; V Jayaraman; S E Coombs
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Suppression of eukaryotic translation termination by selected RNAs.

Authors:  J Carnes; L Frolova; S Zinnen; G Drugeon; M Phillippe; J Justesen; A L Haenni; L Leinwand; L L Kisselev; M Yarus
Journal:  RNA       Date:  2000-10       Impact factor: 4.942

5.  The generality of DNA-templated synthesis as a basis for evolving non-natural small molecules.

Authors:  Z J Gartner; D R Liu
Journal:  J Am Chem Soc       Date:  2001-07-18       Impact factor: 15.419

6.  Searching sequence space for protein catalysts.

Authors:  S V Taylor; K U Walter; P Kast; D Hilvert
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

7.  A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes.

Authors:  Dennis Y Wang; Beatrice H Y Lai; Anat R Feldman; Dipankar Sen
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

8.  Optimization and optimality of a short ribozyme ligase that joins non-Watson-Crick base pairings.

Authors:  M P Robertson; J R Hesselberth; A D Ellington
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

9.  Minihelix-loop RNAs: minimal structures for aminoacylation catalysts.

Authors:  Krishna Ramaswamy; Kenneth Wei; Hiroaki Suga
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

10.  Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serum-stable RNA aptamers.

Authors:  Mihaela Lorger; Markus Engstler; Matthias Homann; H Ulrich Göringer
Journal:  Eukaryot Cell       Date:  2003-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.